Salmon Sperm Facial Explained: How Rejuran PDRN from Seoul Went From Dermatology Staple to Global Beauty Trend

Key Highlights
Introduction
What exactly is PDRN — and why does it come from salmon?
How PDRN acts on skin: cellular mechanisms and expected effects
Treatment formats: injections, microneedling, and topical PDRN
Typical course, costs and timelines for visible results
Evidence: what clinical studies and dermatologists report
Side effects, safety considerations and contraindications
Who benefits most — and who should avoid it
Practicalities: what to expect during a clinic visit and aftercare
Comparisons: PDRN versus Botox, fillers, PRP, and other rejuvenation options
Global spread: how a Seoul dermatology protocol became a celebrity and social media sensation
Ethical, ecological and regulatory questions
Anecdotes and real-world experiences
Questions to ask before booking a PDRN treatment
Integrating PDRN into a broader skincare strategy
Safety signals and what to monitor after treatment
The future of DNA-based regenerative aesthetics
FAQ

Key Highlights

The so-called “salmon sperm facial” uses PDRN (polydeoxyribonucleotide), a purified DNA fragment derived from salmon or trout, to stimulate skin repair and collagen production; it is commonly known as Rejuran in South Korea.
Delivery ranges from medical-grade injections to topical hydrogel or sheet masks; injections require medical expertise and produce measurable regenerative effects, while topical products offer a gentler, lower-concentration alternative.
Benefits include improved skin texture, barrier repair, and reduced fine lines; risks include fish allergy, injection-site reactions, and ethical or sustainability concerns over sourcing.

Introduction

A single phrase — “salmon sperm facial” — provoked amusement, curiosity and headlines when a celebrity mentioned trying it. The reaction collapsed neatly into two camps: instant dismissal as another eccentric wellness fad, and immediate interest from those who follow emerging dermatologic therapies. The truth sits somewhere between. The treatment’s colloquial label obscures a legitimate biomedical technology: polydeoxyribonucleotide (PDRN). Extracted from salmon or trout DNA, PDRN has a history in wound healing and tissue regeneration. Dermatologists in South Korea adapted it into an aesthetic protocol branded widely as Rejuran, and the procedure has spread into clinics and influencers’ routines around the world. Understanding why the practice has traction requires separating the sensational name from the science behind it, examining how the treatment is administered, assessing the clinical evidence, and weighing safety and ethical trade-offs.

The next sections explain what PDRN is, how it works in the skin, how treatments are performed, what evidence supports efficacy, who is a candidate, and what practical questions patients should ask before booking an appointment.

What exactly is PDRN — and why does it come from salmon?

PDRN stands for polydeoxyribonucleotide: short fragments of deoxyribonucleic acid (DNA). These fragments are obtained by purifying DNA extracted from fish—commonly salmon or trout—then processing it to yield specific nucleotide chains that are free from proteins and cellular debris. The final product is a sterile solution of DNA oligonucleotides intended for medical or aesthetic use.

The choice of salmon is not an affectation. Fish DNA is structurally similar to human DNA, and salmon DNA has been noted for a high degree of homology with human sequences, which increases biocompatibility and reduces the likelihood of immune rejection. Historically, PDRN entered medicine as a regenerative agent used for diabetic ulcers, burn wounds and orthopedic indications because of its ability to accelerate tissue repair and modulate inflammation. That regenerative profile made the compound attractive to dermatologists seeking alternatives to traditional anti-aging modalities.

Rejuran is a trade name for a class of PDRN-based aesthetic injectables developed in South Korea. Clinics there—where medicalized skin procedures are culturally mainstream—began using Rejuran to improve skin elasticity, reduce fine lines, and repair a compromised skin barrier. The result is a treatment that markets itself less as a filler or neuromodulator and more as a “healer” for the dermis.

How PDRN acts on skin: cellular mechanisms and expected effects

PDRN’s appeal lies in its biological activity at the cellular level. When introduced into damaged or aging tissue, PDRN appears to trigger several processes:

Stimulation of fibroblasts: Fibroblasts are the primary cells responsible for producing collagen and elastin. PDRN promotes fibroblast proliferation and activity, which translates into increased extracellular matrix production and improved skin firmness over time.
Angiogenesis: PDRN seems to encourage new blood vessel formation, improving tissue perfusion and nutrient delivery. Better vascular supply supports healthier-looking skin and aids repair.
Anti-inflammatory modulation: Some studies and clinical observations show PDRN reduces inflammatory cytokines and improves the microenvironment within damaged tissue, which can accelerate healing and reduce redness.
DNA salvage pathway support: As short DNA fragments, PDRN may provide nucleotides that cells can reuse during repair processes, lowering the metabolic burden on stressed or injured cells.

These mechanisms differ from the action of common cosmetic injectables. Botox acts by blocking neuromuscular signaling to reduce dynamic wrinkles; hyaluronic acid fillers physically replace lost volume. PDRN, by contrast, aims to restore the skin’s regenerative capacity and structural integrity. That’s why proponents describe it as “healing” rather than merely camouflaging signs of aging.

Clinical and patient-reported outcomes tend to show gradual improvement: skin texture becomes smoother, fine lines soften, elasticity improves, and an overall “plumped” or revitalized appearance emerges over the weeks following treatment. Results are cumulative: a series of sessions yields more pronounced effects than a single visit.

Treatment formats: injections, microneedling, and topical PDRN

Clinics offer PDRN in a few different formats, each with different potency, downtime and risk profile.

Intradermal injection (medical-grade Rejuran)

Administration: A trained dermatologist or physician injects diluted PDRN solution into the dermis using fine needles or cannulas. Some practitioners perform a grid of microinjections across the face; others target specific problem areas (nasolabial folds, cheeks, under eyes).
Potency: This is the most concentrated and direct delivery method. Injected PDRN reaches the dermis where fibroblasts reside.
Sensation and recovery: Patients commonly describe a stinging or burning sensation during injection. Immediately after, the face often shows tiny raised bumps or pinpoint bleeding resembling mosquito bites. Swelling and mild bruising can occur. Most of those superficial bumps resolve within 24–48 hours, though minor redness may persist longer.
Regimen: Providers typically recommend a series of three sessions spaced 3–4 weeks apart for initial rejuvenation, followed by maintenance every six to 12 months depending on results and patient goals.

Microneedling with PDRN

Administration: A microneedling device creates controlled microchannels in the epidermis and dermis. A PDRN-containing serum or product is applied topically or injected immediately after microneedling to enhance penetration.
Potency: Microneedling increases PDRN uptake compared with topical application alone. It provides a middle ground between full intradermal injection and over-the-counter masks.
Recovery: Microneedling produces transient redness and pinpoint bleeding; downtime is usually minimal to moderate, depending on needle depth.

Topical hydrogels and sheet masks

Administration: Over-the-counter or clinic-sold hydrogel masks containing low concentrations of PDRN are applied for a set period, often overnight.
Potency: Topical PDRN is far less potent than injections. These products offer a non-invasive, reduced-risk option that may impart transient hydration and mild regenerative stimulus.
Accessibility: These masks are widely distributed on social media and e-commerce platforms, popular among people who want to experiment with the ingredient without committing to injections.

The choice among these formats depends on the patient’s tolerance for needles, desired outcome, and budget.

Typical course, costs and timelines for visible results

Clinicians generally design PDRN treatment plans to maximize cumulative regenerative effects.

Session frequency: Most providers recommend three initial treatments spaced about three to four weeks apart. That schedule allows the regenerative processes—fibroblast activation and collagen deposition—to unfold between sessions.
Maintenance: After the initial series, maintenance sessions are often scheduled every six to 12 months to preserve gains.
Onset of effects: Patients may notice subtle improvements in skin tone and radiance within a week or two. Collagen remodeling and firmer texture typically become more evident at six to eight weeks and continue to evolve for several months.
Duration of benefit: Individual results vary with age, baseline skin quality, lifestyle factors (sun exposure, smoking), and treatment regimen. Many patients report noticeable improvement lasting six months to a year after a full course; maintenance sessions extend duration.

Cost varies widely by geography, clinic, and delivery method. In South Korea, Rejuran injections are commonly priced per syringe and per session; in Western markets, a full face session typically ranges from a few hundred to over a thousand dollars. Microneedling sessions with PDRN elevate cost above standard microneedling, while topical masks are relatively inexpensive and sold for single-use or multi-pack.

Evidence: what clinical studies and dermatologists report

PDRN’s therapeutic uses predate its aesthetic deployment. Historically, studies in wound care and orthopedics demonstrated improved healing rates and pain relief when PDRN was applied to damaged tissue. Those results provided a rationale for investigating skin rejuvenation.

In dermatology, early clinical reports and small controlled trials have documented improvements in skin elasticity, wrinkle depth, and overall texture following PDRN injections. Histologic examinations in some studies revealed increased collagen deposition and neovascularization after treatment. Patient-reported satisfaction in clinic series tends to be high, particularly among those seeking gradual, natural-looking rejuvenation rather than dramatic volume changes.

Limitations of the evidence base include small sample sizes, variability in protocols, and industry sponsorship in some trials. High-quality, large-scale randomized controlled trials comparing PDRN directly with established modalities or sham treatments remain limited. That means clinicians rely on a combination of available clinical data, biological plausibility, and real-world experience when recommending PDRN.

When assessing any emerging aesthetic technology, two points matter: safety profile and reproducibility. PDRN’s safety record is generally favorable in clinical reports, with most adverse events limited to transient injection-site reactions. The reproducibility of outcomes depends on treatment protocol, product quality, and the provider’s technique.

Side effects, safety considerations and contraindications

PDRN is not risk-free. Common immediate effects include:

Localized swelling and redness.
Pinpoint bumps or small papules at injection sites that usually resolve within 24–48 hours.
Bruising where needles puncture capillaries.
Mild discomfort or pain during injection.

Less common but important considerations:

Allergic reaction: Anyone with a known fish or seafood allergy should avoid PDRN products derived from fish, unless a thoroughly validated non-fish alternative exists. Even though PDRN is a purified DNA fragment with most proteins removed, the risk of hypersensitivity cannot be dismissed.
Infection: Any injection carries a small risk of infection. Proper aseptic technique minimizes this chance.
Granulomatous reaction: As with any foreign substance introduced into tissue, rare immune-mediated granulomatous responses have been reported with certain injectables. The risk with highly purified PDRN appears low but is not zero.
Pregnancy and breastfeeding: Safety data in pregnancy or lactation are limited. Most practitioners recommend postponing elective aesthetic injections during pregnancy and breastfeeding.
Immunosuppression: Patients on immunosuppressive therapy or with autoimmune conditions should consult their treating specialist and the injecting physician for individualized risk assessment.

Ethical and environmental concerns:

Sourcing and sustainability: Large-scale harvesting of fish for biomedical or cosmetic use raises questions about sustainable practices and ecological impact. Clinics and manufacturers vary in their transparency about sourcing.
Vegan/ethical objections: The use of animal-derived ingredients makes PDRN unacceptable for vegans and for patients who avoid animal-derived substances for religious or ethical reasons.

Provider and product selection:

Product purity: The safety and efficacy of PDRN depend on rigorous purification and sterile manufacturing. Only use products from reputable manufacturers with clear quality control.
Qualified injector: Because the most effective delivery method is intradermal injection, choose a board-certified dermatologist or qualified aesthetic physician. Technique matters for both safety and outcomes.

Who benefits most — and who should avoid it

Ideal candidates:

People seeking gradual, natural-looking improvement in skin texture and elasticity rather than rapid volume changes.
Patients with thin, fragile skin, acne scarring, or early signs of photo-aging who want to strengthen the skin barrier.
Individuals who have tried topical collagen-boosting treatments and want a medical-grade procedure to amplify results.

Less suitable candidates:

Those seeking immediate, dramatic changes that implants or fillers produce.
People with allergy to fish/seafood, unless a non-fish-derived PDRN product is available and validated.
Pregnant or breastfeeding individuals, unless cleared by a medical provider.
Patients with poorly controlled chronic medical conditions that complicate healing.

A careful consultation should include medical history, allergy screening, realistic expectation setting and discussion of alternative treatments—chemical peels, laser resurfacing, microneedling without PDRN, hyaluronic fillers, or neuromodulators—depending on goals.

Practicalities: what to expect during a clinic visit and aftercare

A typical clinic visit for intradermal PDRN injections proceeds as follows:

Pre-treatment assessment: The clinician reviews health history, medications, recent infections or procedures, and allergy profile. Photographs may be taken for baseline documentation.
Numbing: Topical anesthetic cream is often applied for 20–30 minutes to reduce discomfort. For needle phobia or lower pain thresholds, local anesthetic or nerve blocks may be discussed.
Injection: A grid pattern of microinjections delivers PDRN into the dermis. The provider manipulates depth and spacing to achieve uniform coverage.
Immediate post-care: The face may show erythema and tiny papules. Cold compresses and topical soothing agents can relieve discomfort.
Short-term recovery: Most visible bumps resolve within 24–48 hours. Avoid heavy exercise, saunas, or intense sun exposure for 48–72 hours. Use a gentle skincare regimen—no chemical peels, retinoids, or abrasive exfoliation for a week or per clinician instructions.
Follow-up: Providers often schedule subsequent sessions at three- to four-week intervals during an initial series. Photographic comparisons and patient feedback guide maintenance planning.

For topical PDRN or microneedling sessions, expectations and downtime vary with procedure intensity. Microneedling depth determines recovery time; superficial sessions produce mild redness, while deeper settings require a few days for full recovery.

Comparisons: PDRN versus Botox, fillers, PRP, and other rejuvenation options

PDRN’s niche in aesthetic medicine becomes clearer when compared to other popular treatments.

Botox (neuromodulators): Botox prevents muscle contraction and reduces dynamic wrinkles. Results are quick and reversible. PDRN does not alter muscle activity; it addresses tissue health and structural support.
Hyaluronic acid fillers: Fillers add volume and reshape contours. They produce immediate visible changes. PDRN supports collagen and elastin production; its improvements are gradual and biologically driven rather than volumetric correction.
Platelet-rich plasma (PRP): PRP uses a patient’s own blood to extract growth factors and platelets that support healing. PRP and PDRN share regenerative goals, though mechanisms differ. PRP is autologous; PDRN is an exogenous DNA-based compound. Some clinics combine PRP with PDRN or microneedling to try to synergize effects.
Lasers and chemical peels: Energy-based devices and chemical resurfacing remove layers of damaged tissue and stimulate remodeling. PDRN is less ablative and may be gentler on individuals who prefer minimal downtime.

A personalized plan often blends modalities. For example, microneedling with PDRN may follow a session of fractional laser to capitalize on both resurfacing and regenerative stimuli. Such combinations require careful sequencing to manage risk.

Global spread: how a Seoul dermatology protocol became a celebrity and social media sensation

South Korea is known for its medicalized approach to cosmetic dermatology; clinics there adopt and refine technologies rapidly. Rejuran has become mainstream in Korea, used both in dermatology clinics and medical aesthetics centers. International interest accelerated when celebrities and influencers shared experiences on social media, and when topical PDRN masks became viral on platforms like TikTok.

The journey from specialized medical treatment to consumer trend mirrors previous cycles in beauty: snail mucin and bee venom moved from niche dermatology use to mass-market recognition once results and anecdotes gained traction. The viral spread brings benefits—wider access and consumer awareness—but also risks: oversimplification of protocols, proliferation of low-quality topical products, and misunderstanding of safety requirements for injections.

Clinics outside Korea have imported both the product and technique, adapting protocols to local regulation and patient expectations. In some Western markets, PDRN is offered primarily in specialist dermatology clinics rather than beauty salons, reflecting the medical nature of intradermal administration.

Ethical, ecological and regulatory questions

The rise of PDRN raises questions beyond efficacy.

Sustainability of sourcing: Manufacturing PDRN at scale requires raw biological material. Consumers and practitioners increasingly ask whether suppliers use sustainable aquaculture practices, whether byproducts are ethically sourced, and whether environmental impact is minimized.
Transparency: Manufacturers should disclose sourcing and purification methods so clinicians can evaluate product quality. Clinics can help by choosing suppliers that adhere to environmental and labor standards.
Regulation and labeling: Regulatory oversight for aesthetic products varies by country. Medical-grade PDRN intended for injection should meet sterile manufacturing standards and be approved or cleared by relevant agencies for medical use. Topical PDRN products may fall into cosmetic categories and face less stringent scrutiny. Patients should ask whether a product is intended for intradermal injection, topical application, or both—and whether it is approved for the proposed use in their country.
Informed consent and marketing: The colorful nickname “salmon sperm facial” trivializes the technical nature of the procedure. Marketing materials should provide clear, medically accurate information on risks, realistic outcomes, and the number of sessions required.

Clinicians and patients both share responsibility for making choices aligned with medical ethics and environmental stewardship.

Anecdotes and real-world experiences

Clinic anecdotes and published case series provide texture to clinical data. Patients often report:

Immediate post-injection appearance resembling tiny bumps across the face, which resolve quickly.
Gradual improvement in fine lines and skin smoothness over two to three months.
Preference for the “natural” results compared with fillers or threads, particularly among those seeking subtle rejuvenation.

Social media exaggerations do occur. Some influencers promote topical PDRN masks as a miracle overnight fix, which oversells the modest effects of low-concentration topical formulations. Conversely, many dermatologists caution that dramatic results require medical-grade injections and a properly structured treatment plan.

Real-world experience also highlights variability: older patients with significant volume loss will see different outcomes than younger patients with early photodamage. Combining PDRN with complementary treatments—controlled laser resurfacing, judicious filler use, medical-grade skincare—often yields the best long-term outcome.

Questions to ask before booking a PDRN treatment

A well-informed patient asks targeted questions. Useful topics include:

What exactly is the product brand and its source? Request manufacturer information and sterile certification.
Is the provider board-certified in dermatology or trained in medical aesthetics? Ask about experience with Rejuran or PDRN injections.
How many sessions will I need for my goals, and what are realistic outcomes?
What are the risks specific to my medical history, especially allergies or autoimmune conditions?
Can you show before-and-after images of actual patients treated in your clinic, and are references available?
What post-procedure care is required, and how will complications be handled?
If I want a non-invasive trial, do you offer topical PDRN masks or microneedling with PDRN first?

These questions help distinguish medical-grade practice from casual offerings that may leave patients unhappy or exposed to unnecessary risk.

Integrating PDRN into a broader skincare strategy

PDRN is a tool, not a panacea. Optimal results come from integrating medical procedures with daily skin health practices:

Sunscreen: Protecting new collagen and minimizing further photodamage is essential. Broad-spectrum sunscreen should be daily.
Nutrition and lifestyle: Smoking cessation, adequate sleep, and a balanced diet support tissue repair.
Skincare regimen: Medical-grade retinoids, antioxidants, and moisturizers complement procedural gains once the immediate post-procedure window has passed.
Maintenance plan: Discuss a maintenance schedule with your provider to preserve improvements and avoid dramatic “peaks and valleys.”

Patients who approach PDRN as part of a long-term skin health plan tend to achieve more consistent, satisfying results than those who view it as a one-off quick fix.

Safety signals and what to monitor after treatment

Monitor the treatment area for:

Increasing redness, warmth, or pain beyond the expected initial reaction.
Signs of infection: spreading redness, pus, fever.
Persistent lumps or nodules that do not resolve in the expected timeframe.
Allergic symptoms such as hives or systemic reactions.

Report any concerning findings to the treating clinic immediately. Early evaluation can prevent minor complications from becoming serious.

The future of DNA-based regenerative aesthetics

PDRN exemplifies a broader trend: moving from purely structural aesthetic interventions toward therapies that target regenerative biology. Ongoing research explores optimized oligonucleotide lengths, carrier systems to improve delivery, and combinations with growth factors or stem-cell-derived products to amplify benefits.

Expect more clinical studies in the coming years—larger randomized trials that will better define which populations benefit most and what protocols deliver the best cost-to-benefit ratio. At the same time, regulation and supply-chain transparency will likely evolve as demand grows.

For now, PDRN sits at an intersection: a medical-grade regenerative therapy translated into aesthetic practice; a Korean dermatology innovation embraced by international consumers; and a treatment that prompts both excitement and healthy skepticism. Patients should weigh clinical evidence, provider expertise, personal health factors, and ethical preferences when deciding whether to try it.

FAQ

Q: Is the “salmon sperm facial” actually raw sperm applied to the skin? A: No. The term is a sensational shorthand. The treatment uses PDRN—purified DNA fragments derived from salmon or trout—which are processed and sterilized. Proteins and intact cells are removed during manufacturing; the final product is a biochemical solution intended for injection or topical use, not raw biological material.

Q: Are results immediate? A: Some immediate improvements in radiance or hydration may be noticeable, especially after topical or mild procedures. Meaningful structural changes—improved collagen, firmer skin, reduced fine lines—typically appear gradually over several weeks to months, with cumulative improvement across multiple sessions.

Q: How many treatments will I need? A: Many clinicians recommend an initial series of three sessions spaced three to four weeks apart, followed by maintenance treatments every six to 12 months. Individual needs vary by age, skin condition, and desired outcome.

Q: Does it hurt? A: Injected PDRN can be more uncomfortable than a standard filler session for some patients. Topical anesthetic cream and skilled injection technique reduce pain. Microneedling involves its own level of discomfort and may use numbing. Topical masks are painless.

Q: What are the main risks? A: Common short-term effects include redness, swelling and small papules at injection sites that usually resolve in 24–48 hours. Less common risks are allergic reactions in people with fish allergies, infection, and rare immune responses. Long-term safety data are still emerging.

Q: Can vegans use this treatment? A: No; PDRN is derived from fish DNA, making it unsuitable for vegans and those who avoid animal-derived ingredients for ethical reasons.

Q: Is PDRN regulated by health authorities? A: Regulatory status varies by country. Medical-grade PDRN products intended for injection should comply with local medical-device or pharmaceutical regulations; topical PDRN cosmetics may face less stringent oversight. Verify product approvals and manufacturing standards in your jurisdiction.

Q: How does PDRN compare to PRP? A: Both aim to support tissue regeneration. PRP is autologous (derived from the patient’s blood) and rich in growth factors. PDRN is an exogenous, purified DNA fragment with a different mechanism—supporting fibroblasts, angiogenesis, and nucleotide salvage. Some clinics combine modalities; others prefer one approach depending on goals and patient preference.

Q: Is there a risk of disease transmission from fish-derived products? A: PDRN intended for medical use undergoes purification and sterilization steps designed to remove proteins, cellular material and pathogens. Use products from reputable manufacturers and clinics that can document sterile processing to minimize any theoretical risk.

Q: Where should I seek treatment? A: Choose a board-certified dermatologist or a licensed aesthetic physician experienced in PDRN protocols. Ask about product sourcing, see clinical before-and-after photos from the treating clinic, and request a clear plan for sessions and aftercare.

Q: Are there topical alternatives if I don’t want injections? A: Yes. Hydrogel masks, sheet masks and serums with lower concentrations of PDRN are available and widely used on social media. These provide a milder effect and lower risk but are not equivalent to intradermal injections in potency or outcome.

Q: What should I avoid after treatment? A: Avoid heavy exercise, excessive heat, aggressive skincare treatments (like strong chemical peels or deep exfoliation), and sun exposure for the first 48–72 hours, unless your clinician advises otherwise. Use gentle cleansers and sun protection.

Q: How long do results last? A: Many patients report benefits lasting six months to a year after a full initial course, with maintenance extending results. Individual outcomes depend on age, skin condition, lifestyle, and the treatment regimen.

Q: Is PDRN appropriate for acne scars or pigmentation? A: PDRN may improve skin texture and support remodeling in mild-to-moderate scarring. Pigmentation issues are multifactorial and may require combined approaches (laser therapy, topical lightening agents) for best results. A consultation with a dermatologist will clarify expectations.

Q: What ethical or environmental issues should I consider? A: Ask the clinic or manufacturer about sourcing practices and sustainability claims. If environmental impact or animal-derived ingredients are concerns, discuss alternatives such as PRP, synthetic peptides, or non-animal-derived cosmeceuticals.

Choosing any aesthetic procedure requires balancing scientific evidence, practitioner competence, personal values and realistic expectations. PDRN-based treatments offer a biologically plausible path to improving skin resilience and texture. For patients who seek a regenerative approach and are comfortable with a medical procedure, PDRN represents a meaningful option—provided the product and provider meet high standards for quality and safety.